SEC Form 4 · accession 0001477932-17-004954
Nascent Biotech Inc. · NBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brandon Price
Officer — Senior VP Business Development · Director · 10% Owner
Period of report
Jun 29, 2017
Accepted (ET)
Oct 10, 2017 · 7:37 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001622057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2017 | J | 20,678 | $0.30 | A | 986,378 | D | |
| Common Stock | Sep 28, 2017 | J | 98,354 | $0.248 | A | 1,084,732 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were granted as part of the employment contract with the Company.